Stryker Equipment: 7 Questions Buyers Actually Ask (From a Hospital Purchaser)

I'm the purchasing coordinator for a 240-bed regional medical center. When I took over this role in 2021, I inherited 11 active equipment vendors and no clear replacement schedule. Now I manage roughly $2.3M in annual equipment orders across surgical services, rehab, and patient care, reporting to both operations and finance. I get emails from peers at smaller facilities asking about Stryker equipment. These are the seven questions I get most often — answered the honest way.

1. What does Stryker actually make?

Short answer: a lot. A single purchase order with Stryker can cover surgical instruments, hospital beds, stretchers, orthopedic implants, and OR video equipment. For a purchasing person, that breadth is genuinely valuable — fewer contracts, fewer service relationships, one account team.

Stryker's main segments are MedSurg (hospital beds, patient handling, surgical tools), Orthopaedics (joint implants, robotics), and Neurotechnology (endoscopy, imaging). Walk through our hospital and Stryker equipment shows up in the OR, the ER, the ICU, and the PT gym.

One thing I've learned: people think buying from a big vendor automatically costs more than a patchwork of smaller suppliers. In our case, the opposite was true once we looked at total cost of ownership (i.e., not just unit price but service, training, and downtime). Consolidated purchasing gave us leverage on pricing and support that we never had when orders were split across five companies.

2. What is a bedside monitor?

This question comes up more than you'd think. A bedside monitor is the device in a hospital room that continuously tracks a patient's vital signs — heart rate, blood pressure, oxygen saturation, and often respiratory rate. It's the screen at the bedside with the waveforms and numbers that nurses and clinicians scan constantly.

When we replaced our patient monitoring fleet in 2024, I learned the buying decision is less about hardware and more about software: alarm management, EHR integration, and whether data reaches the nurse's phone instantly. That's where real cost and real value sit. (The screens are the visible part — honestly, the software is the product.)

Stryker's acute care division sells the beds and patient handling equipment that sit right next to those monitors, and bed-to-monitor integration matters more than most people realize. Bed exit alarms, patient turning reminders, and nurse call integration all work better when your bed vendor and monitoring system talk to each other. We didn't buy our bedside monitors from Stryker, but we made sure the ecosystem was compatible — which saved us from a painful integration project later.

3. What should I know about the Stryker Core 2 console?

The Stryker Core 2 console is an integrated surgical tower used in minimally invasive procedures — arthroscopy and laparoscopy mainly. It's the central hub that connects the camera, light source, insufflation, and fluid management into one touchscreen interface. Instead of managing five separate boxes from different vendors, your surgical team works from a single console.

What most people don't realize is that "integrated" doesn't mean plug-and-play with whatever you already own. When we specced the Core 2, I assumed it would connect to our existing OR monitors. Didn't verify. Turned out we needed different cabling and a software license upgrade on the monitors we already had — a five-figure cost I hadn't budgeted for. My advice: ask the Stryker team for a full room integration checklist before you sign, not after. They were helpful once we asked, but nobody volunteered that information upfront.

Like most devices in its class, the Core 2 is FDA-cleared (you can verify the 510(k) in the FDA's public database — something I check on every capital purchase). Bottom line: it's a solid platform, and surgeons who train on it tend to like it. But budget for integration, not just the console price. (This was early 2025 — get a current quote, since pricing structures may have changed.)

4. Is the Stryker total knee replacement video worth showing patients?

I get this one constantly. Patients find the Stryker total knee replacement video online before they ever talk to our surgeons. The official videos Stryker publishes walk through the implant, the procedure, and what recovery actually looks like. They're genuinely well produced — our pre-op nursing staff use them every week.

Is it worth showing? Yes, with one caveat: it's patient education, but it's also a brand awareness tool. That's not a criticism — it's a reminder to review the video with your surgical team before you link to it on your own website or hand it out. We had an orthopedic surgeon ask us to create a companion Q&A sheet because patients were arriving with questions the video didn't answer — plus a few assumptions our surgeons wanted to correct.

Pair the video with someone who can answer follow-up questions and it's a genuinely useful resource. Hand it over cold, and you'll get phone calls full of confusion. The video is a great starting point, not a complete education.

5. What does a gait analysis system do?

A gait analysis system measures how a person walks. Using cameras, force plates, and sometimes wearable sensors, it captures things the naked eye can't: stride asymmetry, joint loading, and how walking patterns change over time.

In our hospital, the ortho and rehab teams use it before and after knee replacements. Patients get a baseline walking assessment, then re-tests at six-week and three-month marks to measure objective progress — not just how the patient feels, which is notoriously unreliable after surgery.

The honest take: it's a smart investment if you're doing high-volume joint replacement and you have clinicians who will actually use the output. We bought ours in 2024 as part of an outcomes research initiative, partly grant-funded. If your team isn't sure how they'd use the data, that's a red flag. You're not buying a machine — you're buying a data workflow. Without the workflow, the equipment collects dust.

6. Does a shockwave therapy device make sense for us?

Shockwave therapy devices use acoustic pressure waves to treat musculoskeletal conditions — plantar fasciitis, Achilles tendinopathy, and calcific shoulder tendonitis are the most common indications. It's a legitimate tool, but it's a niche one.

Here's what I'd tell any buying peer: the device only pays for itself if your patient volume in those specific conditions is high. Our PT department sees enough plantar fasciitis and tendonitis cases that our shockwave therapy device gets used several times a week. If you're hoping it will attract new patients on its own, that's the wrong reason to purchase.

Two practical things to check before any sales conversation. First, does your billing team know how to code shockwave therapy? Reimbursement varies by payer and region (as of January 2025, several major insurers in our state still classify it as non-covered for some indications). Second, confirm who is credentialed to use it — scope-of-practice rules vary by state. I recommend this for a clinic with established ortho or sports medicine volume. If you're a general practice, consider renting before you commit to buying.

7. What's one thing vendors won't tell you about buying Stryker equipment?

Here's something vendors won't tell you: the first quote is almost never the final price for an ongoing relationship. Once you've proven you're a reliable customer — which, as a hospital buying bedside monitors and a Core 2 console in the same year, you are — there's usually room to negotiate. Not necessarily on the device price, but on installation, training hours, service contracts, and trade-in allowances for old equipment.

I went back and forth between the Stryker Core 2 and a competitor's integrated console for two weeks. The competitor's quote was meaningfully lower on paper. What tipped it for me was the five-year cost picture: Stryker's service response time in our region, the upgrade path toward robotics, and the fact that we already had Stryker infrastructure in the OR. That five-year view is what separates a good buying decision from one that only looks good in the current fiscal year.

I hit approve and immediately thought: did I overpay? (There's always a version of that feeling.) I stopped second-guessing when a senior surgeon told me the Core 2 had cut ten minutes off room setup — on a day when OR turnover time was our biggest bottleneck. That's the kind of outcome you can't see on a quote.